Identification and validation of biomarkers assessing the probability of response to treatment of AIT before it is initiated |
Identification and validation of biomarkers assessing the safety of AIT before it is initiated |
Identification and validation of biomarkers confirming the efficacy of AIT in patients receiving AIT (short and long term) |
Identification and validation of biomarkers predicting the long-term effects of AIT before it is stopped |
Identification and validation of biomarkers predicting the relapse of symptoms when AIT is stopped |